These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27861794)

  • 1. Evidence for dual receptor-binding sites in Clostridium difficile toxin A.
    Lambert GS; Baldwin MR
    FEBS Lett; 2016 Dec; 590(24):4550-4563. PubMed ID: 27861794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
    Zhang Y; Hamza T; Gao S; Feng H
    Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain.
    Gerhard R; Frenzel E; Goy S; Olling A
    J Med Microbiol; 2013 Sep; 62(Pt 9):1414-1422. PubMed ID: 23558138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium.
    Yang G; Zhou B; Wang J; He X; Sun X; Nie W; Tzipori S; Feng H
    BMC Microbiol; 2008 Nov; 8():192. PubMed ID: 18990232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and entry of Clostridium difficile toxin B is mediated by multiple domains.
    Manse JS; Baldwin MR
    FEBS Lett; 2015 Dec; 589(24 Pt B):3945-51. PubMed ID: 26602083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B.
    Letourneur O; Ottone S; Delauzun V; Bastide MC; Foussadier A
    Protein Expr Purif; 2003 Oct; 31(2):276-85. PubMed ID: 14550648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.
    Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R
    Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined repetitive oligopeptides of clostridium difficile toxin A counteract premature cleavage of the glucosyl-transferase domain by stabilizing protein conformation.
    Olling A; Hüls C; Goy S; Müller M; Krooss S; Rudolf I; Tatge H; Gerhard R
    Toxins (Basel); 2014 Jul; 6(7):2162-76. PubMed ID: 25054784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A.
    Olling A; Goy S; Hoffmann F; Tatge H; Just I; Gerhard R
    PLoS One; 2011 Mar; 6(3):e17623. PubMed ID: 21445253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality.
    Sauerborn M; Leukel P; von Eichel-Streiber C
    FEMS Microbiol Lett; 1997 Oct; 155(1):45-54. PubMed ID: 9345763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
    Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
    PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells.
    Tao L; Tian S; Zhang J; Liu Z; Robinson-McCarthy L; Miyashita SI; Breault DT; Gerhard R; Oottamasathien S; Whelan SPJ; Dong M
    Nat Microbiol; 2019 Oct; 4(10):1760-1769. PubMed ID: 31160825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward
    Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A
    Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile toxins: mechanism of action and role in disease.
    Voth DE; Ballard JD
    Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
    D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
    BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
    Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
    Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive domain of Clostridium difficile toxin B exhibits cytotoxic effects on human intestinal epithelial cells and decreases epithelial barrier function.
    Zemljic M; Rupnik M; Scarpa M; Anderluh G; Palù G; Castagliuolo I
    Anaerobe; 2010 Oct; 16(5):527-32. PubMed ID: 20620216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
    Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.